Sulodexide Terminated Phase 3 Trials for Diabetic Nephropathies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00462202Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong